Own the Few
Own the Best

Discover the power of our concentrated growth investment strategy
Business Perspectives
Episode 1: Samsara
In this episode of What Matters Most, we explore Samsara’s innovative approach to data collection and visualization. Learn about the company’s rapid growth, market potential, and competitive advantages — as well as what international expansion could mean for the business.
Investment Strategy
International Equities: The Elephant in The Room
As allocators increasingly overweight U.S. equities, we remind them that some of the best growth businesses lie outside the United States. These businesses provide differentiated growth potential, and can also help mitigate downside risk within a diversified portfolio.
Investment Strategy
Decoding Software’s Future
The combination of software and the move to cloud computing remains one of the largest secular growth trends we see, which is driving increased demand for scalable, cloud-based solutions across every sector of the economy.
Business Perspectives
Bringing Governance to AI
Navrina Singh and Credo AI are helping organizations build AI responsibly, by providing an AI governance software platform to ensure technology is fair, compliant, safe, secure, auditable, and human centered.
Investment Culture
Fostering Long-term Thinking
Executive Managing Director and Senior Portfolio Manager Brian Christiansen discusses the importance of candor, collaboration, and entrepreneurialism in creating a culture that promotes long-term thinking.
Investment Strategy
Insights Gained from Past Downturns
Sands Capital portfolio managers reflect on five powerful lessons they have learned while investing through past downturns.
No data was found

Sands Capital exists to add value and enhance the wealth of our clients with prudence over time.

Singular Focus on Growth

Our strategies selectively allocate capital to leading public and private businesses, across the growth spectrum, around the world.

Cultivating Enduring Partnerships

Our skilled professionals are dedicated to delivering on our mission of adding value, while cultivating deep and enduring partnerships with our clients.

Events
Sands Capital Leads Cytovale’s Series D Funding
Sands Capital led Cytovale’s $100 million Series D funding round, enabling commercial and operational expansion of IntelliSep, a rapid diagnostic test cleared by the Federal Drug Administration (FDA), that is transforming sepsis care for hospital emergency departments and health systems nationwide.
Announcements
Sands Capital Co-leads Anduril Industries’ Series F Funding to Hyperscale Defense Manufacturing
This latest funding will help enable the company’s continued growth, enhanced processes, upgraded tooling, expanded infrastructure, and increased supply chain resiliency.
In The News
Sands Capital Retains UK Stewardship Code Signatory Status
The United Kingdom’s Financial Reporting Council has named Sands Capital as a signatory to the UK Stewardship Code for the second year in a row. The UK Stewardship Code was designed to strengthen reporting requirements and stewardship expectations for asset managers, asset owners, and service providers.